• 
  Simon Baldacci, Benjamin Besse, Virginie Avrillon, Bertrand Mennecier, Julien Mazieres, et al.. Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. European Journal of Cancer, 2022, 166, pp.51-59. ⟨10.1016/j.ejca.2022.01.018⟩. ⟨hal-04728569⟩
• 
  Anis Krache, Charlotte Fontan, Carine Pestourie, Manuel Bardiès, Yann Bouvet, et al.. Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model. Frontiers in Medicine, 2022, 8, pp.741855. ⟨10.3389/fmed.2021.741855⟩. ⟨hal-04777861⟩
• 
  Loïs Coënon, Emilie Rigal, Hortense Courot, Caroline Multrier, Sara Zemiti, et al.. Generation of non-genetically modified, CAR-like, NK cells. Journal for Immunotherapy of Cancer, 2024, 12 (7), pp.e009070. ⟨10.1136/jitc-2024-009070⟩. ⟨hal-04777713⟩
• 
  Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1049), ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
• 
  J. Guigay, C. Ortholan, D. Vansteene, D. Cupissol, C. Even, et al.. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial. The Lancet. Healthy longevity, 2024, 5 (3), pp.e182--e193. ⟨10.1016/s2666-7568(23)00284-2⟩. ⟨hal-04661312⟩
• 
  Joël Guigay, Hervé Le Caer, François-Régis Ferrand, Lionel Geoffrois, Esma Saada-Bouzid, et al.. Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial. The Lancet. Healthy longevity, 2024, ⟨10.1016/S2666-7568(24)00048-5⟩. ⟨hal-04578230⟩
• 
  Francois Gouin, Audrey Michot, Mehrdad Jafari, Charles Honoré, Jean Camille Mattei, et al.. Improved metastatic-free survival after systematic re-excision following complete macroscopic unplanned excision of limb or trunk soft tissue sarcoma. Cancers, 2024, 16 (7), pp.1365. ⟨10.3390/cancers16071365⟩. ⟨hal-04653665⟩
• 
  Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, Nesrine Mabrouk, Gauthier Gadouas, et al.. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination. iScience, 2024, 27 (8), ⟨10.1016/j.isci.2024.110441⟩. ⟨hal-04770811⟩
• 
  Rayan Kabirian, Maria Alice Franzoi, Julie Havas, Charles Coutant, Olivier Trédan, et al.. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer. JAMA Network Open, 2023, 6 (11), pp.e2343910. ⟨10.1001/jamanetworkopen.2023.43910⟩. ⟨hal-04765786⟩
• 
  Pierre-Emmanuel Colombo, Marine Lefevre, Laure Delmond, Drissa Traore, William Jacot, et al.. Oncoplastic Resection of Breast Cancers Located in the Lower-Inner or Lower-Outer Quadrant with the Modified McKissock Mammaplasty Technique. Annals of Surgical Oncology, 2015, 22 (S3), pp.486 - 494. ⟨10.1245/s10434-015-4727-5⟩. ⟨hal-01913732⟩
• 
  Céline Bourgier, Claire Lemanski, Pascal Fenoglietto, David Azria. Le grand débat : cancers du sein pN1mi – pour l’irradiation des aires ganglionnaires. Cancer/Radiothérapie, 2018, 22 (6-7), pp.478-480. ⟨10.1016/j.canrad.2018.07.129⟩. ⟨hal-02284987⟩
• 
  Owen Zacarias, Cristina Clement, Shu-Yuan Cheng, Melissa Rosas, Christina Gonzalez, et al.. Mitomycin C and its analog trigger cytotoxicity in MCF-7 and K562 cancer cells through the regulation of RAS and MAPK/ERK pathways. Chemico-Biological Interactions, 2024, 395, pp.111007. ⟨10.1016/j.cbi.2024.111007⟩. ⟨hal-04762226⟩
• 
  Kaiyuan Gong, Baptiste Magnier, Salomé L’hostis, Fanny Borrely, Sébastien Le Bon, et al.. Predicting Response to [177Lu]Lu-PSMA Therapy in mCRPC Using Machine Learning. Journal of Personalized Medicine, 2024, 14 (11), pp.1068. ⟨10.3390/jpm14111068⟩. ⟨hal-04755664⟩
• 
  Gunjan Kayal, Nathaly Barbosa, Carlos Calderón Marín, Ludovic Ferrer, José-Alejandro Fragoso-Negrín, et al.. Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study. Journal of Nuclear Medicine, 2024, 65 (1), pp.125-131. ⟨10.2967/jnumed.122.265340⟩. ⟨hal-04753484⟩
• 
  Rebecca Grossman, Olivia Sgarbura, Julie Hallet, Kjetil Søreide. Social media in surgery: evolving role in research communication and beyond. Langenbeck's Archives of Surgery, 2021, 406 (3), pp.505 - 520. ⟨10.1007/s00423-021-02135-7⟩. ⟨hal-04748908⟩
• 
  Gilles Boni, Vincent Placet, Marina Grimaldi, Patrick Balaguer, Sylvie Pourchet. Toward the manufacturing of a non-toxic high-performance biobased epoxy–hemp fibre composite. Polymers, 2024, Advances in the Processing and Application of Polymers and Their Composites III, 16, pp.2010 (15). ⟨10.3390/polym16142010⟩. ⟨hal-04745627⟩
• 
  Sulov Saha, Clémence Debacq, Christophe Audouard, Thomas Jungas, Pierrick Dupre, et al.. Acute dietary methionine restriction highlights sensitivity of neocortex development to metabolic variations. 2024. ⟨hal-04735417⟩
• 
  Aude Boulay, Emmanuel Quevarec, Isabelle Malet, Giuseppe Nicastro, Célia Chamontin, et al.. A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import. EMBO Molecular Medicine, 2024, ⟨10.1038/s44321-024-00143-w⟩. ⟨hal-04728912⟩
• 
  Mounira Chalabi-Dchar, Olivia Villeronce, Julie Ripoll, Anne Vincent, Tanguy Fenouil, et al.. Translational control of cell plasticity drives 5-FU tolerance. 2024. ⟨hal-04728612⟩
• 
  Sarah Figarol, Célia Delahaye, Rémi Gence, Aurélia Doussine, Juan Pablo Cerapio, et al.. Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies. Nature Communications, 2024, 15 (1), pp.5345. ⟨10.1038/s41467-024-49360-4⟩. ⟨hal-04727333⟩

1 134

1 090